RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…
RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…
RT @EmilioOrtegaMdV: IECA/ARA2: menor mortalidad en pacientes ingresados por COVID19. Mejor calidad de estudio diferentes noticias. Circula…
RT @rincondesisifo: (Circulation) Uso de IECA y ARA2 en pac con HTA y #COVID19 hospitalizados y riesgo de mortalidad https://t.co/iRkVpyypE…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
Important observational study with strong pointer of ACEI/ARB been COVID-protective.
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @EMBoardBombs: FINALLY- logic prevails... Stop taking pts off their ACEB/ARBs. We wait for good data to make big decisions #meded #thisi…
RT @salvacuesta: La (cada vez más) inestable evidencia https://t.co/QMbsKD5aEl
RT @accpcritprn: ACE/ARB for Hypertension in COVID-19. Observational data from China suggests no harm and a possible 28-day mortality benef…
RT @EMBoardBombs: FINALLY- logic prevails... Stop taking pts off their ACEB/ARBs. We wait for good data to make big decisions #meded #thisi…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @SABOURETCardio: Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mort…
RT @CircRes: Are ACE/ARB inhibitors safe for #COVID19 patients? https://t.co/FGsCthPS24 A new observational study suggests that use of #A…
Worth looking at more closely
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @doctormutlu: Among hospitalized COVID-19 patients with hypertension, inpatient use of ACEI/ARB was associated with lower risk of all-ca…
La (cada vez más) inestable evidencia
RT @EMBoardBombs: FINALLY- logic prevails... Stop taking pts off their ACEB/ARBs. We wait for good data to make big decisions #meded #thisi…
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
Eye opening. The opposite of what people were speculating 🤔
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @EMBoardBombs: FINALLY- logic prevails... Stop taking pts off their ACEB/ARBs. We wait for good data to make big decisions #meded #thisi…
RT @EMBoardBombs: FINALLY- logic prevails... Stop taking pts off their ACEB/ARBs. We wait for good data to make big decisions #meded #thisi…
RT @EMBoardBombs: FINALLY- logic prevails... Stop taking pts off their ACEB/ARBs. We wait for good data to make big decisions #meded #thisi…
ACE/ARB for Hypertension in COVID-19. Observational data from China suggests no harm and a possible 28-day mortality benefit (after adjustment for age, gender, co-morbidities, and in-hospital medications) in ~1100 patients. https://t.co/YwHCuFG7jF https://
RT @NightShiftMD: It might just block the pathway through which #COVID19 penetrates the lungs.
FINALLY- logic prevails... Stop taking pts off their ACEB/ARBs. We wait for good data to make big decisions #meded #thisissciencenotmagic #foamed. Thanks for posting Dr. Rezaie
RT @fernando_bernal: Este artículo refuerza hipótesis de que pcte con IECA tienen efecto protector en mortalidad por #COVID19, una de las p…
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @SABOURETCardio: Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mort…
朗報👍
RT @MrinalPatnaik: Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Morta…
RT @catcardiocamfic: En pacients hospitalitzats amb #COVID19 amb HTA, l’us d’IECA/ARA2 es va associar a menor mortalitat que en els que no…
RT @catcardiocamfic: En pacients hospitalitzats amb #COVID19 amb HTA, l’us d’IECA/ARA2 es va associar a menor mortalitat que en els que no…
RT @EmilioOrtegaMdV: IECA/ARA2: menor mortalidad en pacientes ingresados por COVID19. Mejor calidad de estudio diferentes noticias. Circula…
RT @MartinQuirosMD: Análisis retrospectivo de pacientes que tomaban IECA/ARAII (publicado en Circulation). Se asoció con < mortalidad. L…
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
@jaxbarrett50 @AngryMotorcycle
RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @tyonarock: ACEI/ARBの使用とCOVID-19の予後との関係 中国からの報告 1128人のCOVID-19陽性高血圧患者 188人ACEI/ARBの使用:3.7%死亡 940人ACEI/ARBの不使用:9.8%死亡 有意差ありという結果 https…
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @Rocioluarca: Para liarla más....
RT @ruizjuanc: Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality…
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @catcardiocamfic: En pacients hospitalitzats amb #COVID19 amb HTA, l’us d’IECA/ARA2 es va associar a menor mortalitat que en els que no…
RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @SantasEnrique: Datos que de nuevo refuerzan NO suspender IECA/ARA-2 en pacientes con HTA 🏥 por #COVID19. Menor riesgo de mortalidad e…
Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19 | Circulation Research https://t.co/ewo8zgk1Zl
Retrospective, matched study of patients with #COVID and hypertension shows a strong benefit of ACE/ARB inhibition: https://t.co/1Col24CdBL. (h/t @AbbateAntonio) @DaveDixonPharmD, what do you think?
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @ABsteward: Surprising! @CircRes @CircAHA Among hospitalized COVID-19 patients with hypertension, inpatient use of ACEI/ARB was associat…
RT @SantasEnrique: Datos que de nuevo refuerzan NO suspender IECA/ARA-2 en pacientes con HTA 🏥 por #COVID19. Menor riesgo de mortalidad e…
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @doctormutlu: Among hospitalized COVID-19 patients with hypertension, inpatient use of ACEI/ARB was associated with lower risk of all-ca…
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
Among hospitalized COVID-19 patients with hypertension, inpatient use of ACEI/ARB was associated with lower risk of all-cause mortality compared with ACEI/ARB non-users, https://t.co/KoC1xIlWNZ, @TKDsosyal #COVID19 #Covid2019TR https://t.co/gaGoQZgkGy
“Inpatient use of ACEI/ARB was associated with lower risk of all-cause mortality compared with ACEI/ARB non-users.” https://t.co/gcCDkfiiuj
RT @SABOURETCardio: Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mort…
RT @Shanwan57931330: Interesting
RT @PrXavierGirerd: Diminution de 60% de la mortalité par #COVID19 chez les patients ayant une #hypertension artérielle par l'utilisation…
Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19 | Circulation-the link https://t.co/WM0E7yVPT9
V interesting, yet many confounders. Cont'd or new Rx? Pts able to cont are not in shock/renal failure so there is selection bias. Conclusions seem fair though "...unlikely that in-hospital use of ACEI/ARB was associated with an increased mortality risk."
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @venkmurthy: I coauthored editorial on the paper w/ @RaviShah_MD Paper isn't perfect. *Lots* of limitations. Many of which are pointed…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @Rocioluarca: Para liarla más....
RT @SantasEnrique: Datos que de nuevo refuerzan NO suspender IECA/ARA-2 en pacientes con HTA 🏥 por #COVID19. Menor riesgo de mortalidad e…
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @MartinQuirosMD: Análisis retrospectivo de pacientes que tomaban IECA/ARAII (publicado en Circulation). Se asoció con < mortalidad. L…
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
Héroes 🦸♂️ o Villanos 😈???
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @DanielJDrucker: Association Nation #COVID19 “Lower risk of COVID-19 mortality in patients who received ACEI/ARB versus those who did no…